Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway.
Hsieh. Ming-Jer MJ; Lee. Cheng-Hung CH; Chueh. Ho-Yen HY; Chang. Gwo-Jyh GJ; Huang. Hsiu-Yun HY; Lin. Yuling Y; Pang. Jong-Hwei S JS
Key Findings
- BPC‑157 causes dose‑dependent vasodilation in isolated rat aorta, mainly via the endothelium.
- The vasodilation is nitric‑oxide dependent; blocking NO production stops the effect.
- BPC‑157 activates the Src‑Caveolin‑1‑eNOS pathway, reducing the inhibitory binding of Caveolin‑1 to eNOS and promoting NO generation and endothelial cell migration.
Practical Outcomes
- For biohackers, BPC‑157 may be useful for supporting vascular health, blood flow, and tissue repair, but the study is limited to rats and does not provide human dosing guidelines. It suggests that any protocol using BPC‑157 should aim for doses that achieve measurable blood levels while monitoring vascular responses, and that more human research is needed before definitive recommendations.
Summary
In simple terms, the study shows that the peptide BPC‑157 can widen blood vessels in rats by triggering the cells that line the vessels to make more nitric oxide, a molecule that relaxes vessels. This effect depends on the dose and works through a specific signaling chain (Src‑Caveolin‑1‑eNOS). The peptide also helps endothelial cells move, which is important for repairing blood vessels.
Abstract
BPC 157-activated endothelial nitric oxide synthase (eNOS) is associated with tissue repair and angiogenesis as reported in previous studies. However, how BPC 157 regulates the vasomotor tone and intracellular Src-Caveolin-1 (Cav-1)-eNOS signaling is not yet clear. The present study demonstrated a concentration-dependent vasodilation effect of BPC 157 in isolated rat aorta. Attenuation of this vasodilation effect in the absence of endothelium suggested an endothelium-dependent vasodilation effect of BPC 157. Although slightly increased vasorelaxation in aorta without endothelium was noticed at high concentration of BPC 157, there was no direct relaxation effect on three-dimensional model made of vascular smooth muscle cells. The vasodilation effect of BPC 157 was nitric oxide mediated because the addition of L-NAME or hemoglobin inhibited the vasodilation of aorta. Nitric oxide generation was induced by BPC 157 as detected by intracellular DFA-FM DA labeling which was capable of promoting the migration of vascular endothelial cells. BPC 157 enhanced the phosphorylation of Src, Cav-1 and eNOS which was abolished by pretreatment with Src inhibitor, confirming the upstream role of Src in this signal pathway. Activation of eNOS required the released binding with Cav-1 in advance. Co-immunoprecipitation analysis revealed that BPC 157 could reduce the binding between Cav-1 and eNOS. Together, the present study demonstrates that BPC 157 can modulate the vasomotor tone of an isolated aorta in a concentration- and nitric oxide-dependent manner. BPC 157 can induce nitric oxide generation likely through the activation of Src-Cav-1-eNOS pathway.
Study Information
pubmed
2020
2020-10-13T00:00:00.000Z
10.1038/s41598-020-74022-y
40
49